Oxygen use and carbon dioxide production after stabilizing blood flow in shock
Official title: Oxygen Consumption And Carbon Dioxide Production Following Hemodynamic Optimization In Shock: The OxyCarDio Study
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07107724 · Data updated 2026-11-12
This project will see if giving fluids or norepinephrine to adults in the ICU with shock changes how much oxygen their bodies use and how much carbon dioxide they make, measured from the ventilator and compared with blood gas calculations.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Roma) |
| Status | Recruiting |
| Started | July 29, 2025 |
| Main results expected | July 2027 |
| Study ends | December 2027 |
| Registry record updated | August 6, 2025 |
| Trial ID | NCT07107724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Mechanically ventilated adults in the ICU with hypotension and signs of hypoperfusion (for example low urine output, high lactate, or tachycardia) who are candidates for fluid bolus or vasopressor adjustment are ideal candidates.
✕Probably not a fit
Patients with severe respiratory failure or ARDS, those on or needing veno-arterial ECMO or continuous renal replacement therapy, imminently dying patients, pregnant patients, or those with do-not-resuscitate orders are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study in adult ICU patients with signs of shock who receive standard hemodynamic optimization such as fluid boluses or vasopressors. VO2 and VCO2 will be measured continuously using a dedicated ventilator-based gas monitor and compared with values calculated from veno-arterial dissolved gas measurements. Patients will also receive advanced hemodynamic monitoring with the MostCare Up device and clinical management will follow current guidelines and treating physicians' decisions. The study aims to describe immediate changes in exhaled gas metrics after common resuscitation maneuvers and to test agreement between exhaled and blood-based measurements.
Why it matters
Potential benefit: If successful, this approach could provide a noninvasive, bedside way to track tissue oxygen use and guide resuscitation in ventilated patients with shock.
How similar studies have gone: Some prior studies have shown feasibility of measuring VO2 and VCO2 from exhaled gas in ventilated patients, but direct comparison with veno-arterial dissolved gas and response to hemodynamic maneuvers remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Hypotension (MAP\< 65mmHg or sudden drop in MAP \> 15 mmHg) and one of the following conditions: * Heart rate \> 120 bpm * Urinary output \< 0.5 ml/kg/h for at least two hours * Lactate \> 2 mmol/L Exclusion Criteria: * Urgent need for surgery * Urgent need for veno-arterial ECMO or severe hemodynamic instability * Consistent risk of imminent death * Severe ARDS or severe respiratory failure (p/F \< 100 mmHg) and/or FiO2\>0.8 * Severe heart failure (NYHA 4 and/or EF\<25%) * Need for intermittent or continuous renal replacement therapy (IRRT or CRRT) * Anemia defined as Hb\<8 g/dL * VO2 variability \< 5% throughout ten minutes of stabilization before procedure start * Intraabdominal hypertension, defined as intraabdominal pressure \> 18 mmHg * Pregnancy * Withdrawal or refuse of informed consent * Terminal disease * Do-not-resuscitate order.
Where it's running
-
Policlinico Universitario Fondazione Agostino Gemelli IRCCS
Roma, Italy Recruiting
Study contacts
- Study coordinator: Antonio M Dell'Anna
- Email: antoniomaria.dellanna@policlinicogemelli.it
- Phone: +39 0630154490
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative NPAR and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery
This study checks if the preoperative neutrophil percentage-to-albumin ratio (NPAR) can flag who might become hemodynamically unstable after anesthesia induction in adults having major cancer surgery.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Mindfulness-based breathing before spinal anesthesia for elective cesarean delivery
This trial will test whether a 5-minute mindfulness slow-breathing exercise just before spinal anesthesia can reduce blood pressure drops and anxiety in pregnant women having elective cesarean delivery.
-
Electrical stimulation plus isometric exercise to improve blood flow in resistant high blood pressure
This will try whether adding upper‑thoracic electrical stimulation (TENS) and isometric exercise to usual blood pressure medications can lower blood pressure and improve peripheral blood flow in men and women aged 50–60 with resistant hypertension.
-
Predicting fluid responsiveness using PLR, PPV, and LVOT VTI in ICU patients
In critically ill adults on ventilators, researchers test whether measuring LVOT VTI during a passive leg raise can help predict who will respond to fluid therapy.
-
Non-invasive continuous blood pressure monitoring during intracranial aneurysm coil embolization
This trial tests whether the ClearSight non‑invasive continuous blood pressure monitor can safely replace radial arterial catheter monitoring for adults having coil embolization of unruptured intracranial aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.